Clinical Trial Update: Lithium Drug-Drug Interaction Study With Lurasidone HCl [Phase 1]

View source ↗

Summary

The Phase 1 trial update reports completion of a lithium and lurasidone hydrochloride drug-drug interaction study in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Lithium (Lithium carbonate)
• lurasidone hydrochloride (Latuda) (lurasidone hydrochloride)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED